Evaluation of Lung Nodule Detection With Artificial Intelligence Assisted

Status Not yet recruiting

Clinical Trial Summary

Lung cancer is one of the leading cause of cancer related death in China. Lung cancer screening with low-dose computed tomography was considered as a better approach than radiography. However, the role of Lung cancer screening with Low-dose CT (LDCT) among Chinese people remains unclear. With rapid development of artificial intelligence (AI),the application of AI in detection and diagnosis of diseases has become research focus. Moreover, patients' psychological status also plays an important role in diagnosis and treatment.

This study focuses on detection and natural history management of lung nodule and lung cancer with AI assisted chest CT among people living in North China, and aims to investigate epidemiological results, patients' medical records and social psychological status.

Clinical Trial Description

Lu'an Municipal Hospital and North China Petroleum Bureau General Hospital initialed the lung cancer screening by LDCT a few years ago. People living in North China who are administrated by these hospitals routinely took a chest CT every year. This study is to the best of our knowledge the first one designed to combine lung nodule and lung cancer screening with the application of artificial intelligence in China.

Methods: Firstly, the study acquires epidemiological, medical information and psychological status of people recruited, and investigates the data acquired from past several years of CT scans using AI to develop a model for lung nodule detection. Secondly, evaluating the performance of models and apply it to analyse the CT scans from the North China population recruited. Thirdly, improving the model and adding function for lung nodule prediction of natural history and probability of malignancy.

Aims: To depict the epidemiological results about the incidence of lung nodules and lung cancer in North China population; To evaluate association between people 's epidemiological, medical and psychological profiles and incidence, diagnosis and treatment of lung nodule; To develop an artificial intelligence assisted lung nodule diagnosis and management software to assist strategies of CT screening. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03487952
Study type	Observational
Source	Peking University People's Hospital
Contact	Jun J Wang, MM
Phone	+8601088326650
Email	xiongwai@263.net
Status	Not yet recruiting
Phase
Start date	April 2018
Completion date	December 2021

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT05066776` - Liquid Biopsy With PET/CT Versus PET/CT Alone in Diagnosis of Small Lung Nodules
Completed	`NCT01958931` - Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer	N/A
Recruiting	`NCT03528733` - Feasibility of Multi-Energy Digital Radiography Detector for Lung Lesions Detection	N/A
Recruiting	`NCT02693496` - Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research
Completed	`NCT01566682` - A Multi-Center Trial of the ProLung Test™
Terminated	`NCT02983903` - Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions	N/A
Terminated	`NCT02050724` - ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT	Phase 2
Not yet recruiting	`NCT04615156` - 18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography	Phase 3
Recruiting	`NCT02726633` - Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer	N/A
Active, not recruiting	`NCT02623712` - The Watch the Spot Trial	N/A
Recruiting	`NCT03568799` - 4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules	N/A
Not yet recruiting	`NCT02817048` - Tubeless VATS for Peripheral Lung Nodule	N/A
Recruiting	`NCT01149187` - Usefulness of Interferon-gamma Release Assay in Diagnosing Pulmonary Nodules	N/A
Completed	`NCT00925210` - Bronchoscopic Approach to the Peripheral Lung Nodule - An Alternative Approach	Phase 2
Completed	`NCT02448225` - 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules	Phase 2
Active, not recruiting	`NCT05171491` - LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
Terminated	`NCT04140474` - Evaluation of the Archimedes ™ System for Transparenchymatous Access to Pulmonary Nodules.	N/A
Withdrawn	`NCT05804435` - iNod™ Ultrasound-Guided Needle Biopsy System Study	N/A
Not yet recruiting	`NCT02653859` - Evaluate the Auxiliary Diagnostic Value of Circulating Tumor Cells in Benign and Malignant Lung Nodules	N/A
Completed	`NCT02832284` - iNod System Human Feasibility Assessment	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of Lung Nodule Detection With Artificial Intelligence Assisted Computed Tomography in North China

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms